نتائج البحث

Tumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism-A Potential Pathogenic Effector of Atherosclerosis in Cancer.

• Authors : Chen Y; Thrombosis Research Institute, London SW3 6LR, UK.; Scully M

Subjects: Mucin-1*/Mucin-1*/Mucin-1*/metabolism ; Mucin-1*/Mucin-1*/Mucin-1*/genetics ; Cholesterol*/Cholesterol*/Cholesterol*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2026 Jan 04; Vol. 27 (1). Date of Electronic Publication: 2026 Jan 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Cholesterol uptake capacity of HDL in culture medium of fresh primary human hepatocytes: an in vitro system for screening anti-atherosclerosis drugs focused on HDL functions.

• Authors : Hata K; Akita Research Institute of Food and Brewing, 4-26 Sanuki, Araya-machi, Akita, 010-1623, Japan.; Okada T

Subjects: Hepatocytes*/Hepatocytes*/Hepatocytes*/metabolism ; Hepatocytes*/Hepatocytes*/Hepatocytes*/drug effects ; Eicosapentaenoic Acid*/Eicosapentaenoic Acid*/Eicosapentaenoic Acid*/pharmacology

• Source: BMC research notes [BMC Res Notes] 2025 Nov 13; Vol. 18 (1), pp. 480. Date of Electronic Publication: 2025 Nov 13.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500

تفاصيل العنوان

Frog Skin Antimicrobial Peptide 3-13 and Its Analogs Alleviate Atherosclerosis Cholesterol Accumulation in Foam Cells via PPARγ Signaling Pathway.

• Authors : Yang XF; School of Life Science, Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian 116029, China.; School of Basic Medical Sciences, Department of Physiology, Jinzhou Medical University, Jinzhou 121000, China.

Subjects: PPAR gamma*/PPAR gamma*/PPAR gamma*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

• Source: Cells [Cells] 2025 Sep 19; Vol. 14 (18). Date of Electronic Publication: 2025 Sep 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol-Induced Degradation of Phosphatase in Atherosclerosis.

• Authors : Ding J; School of Forensic Medicine, Guizhou Medical University, Guiyang, China.; Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, Guizhou Medical University, Guiyang, China.

Subjects: Apolipoprotein E4*/Apolipoprotein E4*/Apolipoprotein E4*/genetics ; Apolipoprotein E4*/Apolipoprotein E4*/Apolipoprotein E4*/metabolism ; Cholesterol*/Cholesterol*/Cholesterol*/metabolism

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2025 Aug; Vol. 31 (8), pp. e70536.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium: Internet ISSN: 1755-5949

تفاصيل العنوان

MiR-7683-3p from M2-exosomes attenuated atherosclerosis by activating the PPARγ-LXRα-ABCG1 pathway mediated cholesterol efflux of vascular smooth muscle cell derived foam cells.

• Authors : Wang S; Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Animal Experimental Center, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 102300, China.; Lv Y

Subjects: Foam Cells*/Foam Cells*/Foam Cells*/metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 1*/ATP Binding Cassette Transporter, Subfamily G, Member 1*/ATP Binding Cassette Transporter, Subfamily G, Member 1*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2025 Sep 29; Vol. 23 (1), pp. 618. Date of Electronic Publication: 2025 Sep 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux.

• Authors : Ma C; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300381, China.; State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.

Subjects: Glycolysis*/Glycolysis*/Glycolysis*/drug effects ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

• Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Jun; Vol. 12 (23), pp. e2500610. Date of Electronic Publication: 2025 May 21.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway.

• Authors : Zhang M; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou 310000, China.; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, Hangzhou 310000, China.

Subjects: Toll-Like Receptor 9*/Toll-Like Receptor 9*/Toll-Like Receptor 9*/metabolism ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism

• Source: Biomolecules [Biomolecules] 2025 Jul 25; Vol. 15 (8). Date of Electronic Publication: 2025 Jul 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

تفاصيل العنوان

Remnant cholesterol, low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: a cohort study.

• Authors : Zhou D; Department of Epidemiology and Biostatistics, School of Basic Medicine, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing, 100005, China.; Zhou M

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/pathology

• Source: Lipids in health and disease [Lipids Health Dis] 2025 Nov 04; Vol. 24 (1), pp. 352. Date of Electronic Publication: 2025 Nov 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

تفاصيل العنوان

Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota.

• Authors : Wang, Chuan^1,2,3 (AUTHOR); Xing, Junyue^1,2,4 (AUTHOR); Zhao, Huan⁵ (AUTHOR)

• Source: Bioengineering & Translational Medicine. Nov2025, Vol. 10 Issue 6, p1-18. 18p.

تفاصيل العنوان

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux.

• Authors : Chen S; Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.; Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.

Subjects: Oxides*/Oxides*/Oxides*/chemistry ; Oxides*/Oxides*/Oxides*/pharmacology ; Manganese Compounds*/Manganese Compounds*/Manganese Compounds*/chemistry

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Oct 28; Vol. 22 (1), pp. 664. Date of Electronic Publication: 2024 Oct 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان